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ABSTRACT 
Epilepsy is a neurological disorder characterized by unprovoked, recurring seizures that dis-
rupts the nervous system and can cause mental and physical dysfunction. Based on the ethno 
pharmacological information of the plant, the methanolic and aqueous extracts of the flowers 
of Nepeta bractaeta was evaluated for its antiepileptic activity. The methanolic and aqueous 
extracts of the flowers of Nepeta bracteata were observed for their antiepileptic activity by 
increased current Electroshock seizures (ICES) test and Pentylenetetrazole (PTZ) test using 
Swiss albino mice. Both the extracts showed significant activity in ICES and PTZ induced 
convulsions in comparison to control. In ICES model, NBAE at higher dose showed 16.7 % 
and NBME at higher dose showed 33.3 % protection against seizure and in PTZ model, 
NBME at higher dose showed 33.3 % protection against seizure. From the experiments per-
formed, it can be said that Nepeta bractaeta does possess anticonvulsant property.  
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Abbreviations: Nepeta bractaeta– NB, Increased current electroshock seizures – ICES, Pen-
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methanolic extract 
 
 
 
INTRODUCTION 
Natural medicines are gaining promi-
nence because of their economic benefit, 
ease of availability and relatively less side 
effects when compared to allopathic medi-
cines. They have been investigated till now 
and found to treat effectively many diseases 
like cancer, ulcers, infections, heart disor-
ders along with neurological disorders 
mainly epilepsy, schizophrenia, dementia 
etc. Epilepsy is a neurological disorder 
characterized by unprovoked, recurring sei-
zures that disrupt the nervous system and 
can cause mental and physical dysfunction. 
Approximately 50 million individuals suf-
fer from this debilitating disease (Fisher 
and Boas, 2005). 
There are numbers of synthetic antiepi-
leptic drugs currently available in the man-
agement, control and/or treatment of epi-
lepsy. The current therapeutic treatment of 
epilepsy with modern antiepileptic drugs 
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(AEDs) is associated with side-effects, 
dose-related chronic toxicity, teratogenicity 
effects and approximately 30 % of the pa-
tients continue to have seizures with current 
AEDs therapy (Stefan and Wang, 2004). 
Natural products from folk remedies 
have contributed significantly in the dis-
covery of modern drugs and can be an al-
ternative source for the discovery of AEDs 
with novel structures and better safety and 
efficacy profiles (Raza and Shaheen, 2001-
2003). Now, various phytochemical and 
pharmacological studies have been carried 
out on these anticonvulsant plants. Herbal 
medicines are often considered to be a gen-
tle and safe alternative to synthetic drugs. 
More than half of the medically important 
pharmaceutical drugs are either natural 
products or derivatives of natural products 
(Cragg and Newman, 1997; Nassiri-Asl and 
Shariati-Rad, 2008).  
Nepeta bractaeta is an aromatic peren-
nial herbaceous plant of Lamiaceae family; 
it is a brightly colored shrub or sub-shrub 
that ranges from 30-100 cm in height. 
Found in western temperate Himalayas 
from Garhwal to Kashmir at altitudes of 
1800-2400 m. Leaves are ovate-obtuse. 
During summer the plant produces bunches 
of pink blue and more rarely white fragrant 
flowers (Bronlund et al., 2008; Kokkini and 
Vokou, 1989). A syrup prepared from the 
leaves, flowers and seeds is reported to be 
useful in cough and fever (Jamzad, 2001). It 
is also reported to be used in, boils and ab-
scesses, cystitis, gastritis, fever, rheuma-
tism, cold (Amini, 1997), cough, asthma, 
earache, insect bites, flatulence (Vohora, 
1986; Amini, 1997). The major classes of 
chemical constituents present in this plant 
are carbohydrate, flavonols, phenolics, sap-
onins (Kokate, 1994). 
 
MATERIALS AND METHODS 
Plant material 
The flowers of Nepeta bractaeta were 
purchased from Shamsi Dawak-hana, Bal-
limaran, Delhi-110006, India. The authen-
ticity and identity was confirmed on the ba-
sis of classical description in Unani litera-
ture at Department of Ilmul Advia F/O 
Medicine (u), Jamia Hamdard, New Delhi 
and modern Botanical information was es-
tablished by matching with the specimens 
available at the National Institute of Sci-
ence Communications. The wealth of India 
division, Dr. K. Krishnan Marg, New Delhi, 
100012. Reference no. of drug sample 
NISCAIR/RHMD 1656/254. Voucher de-
posited in D/O Ilmul-Advia F/O Medicine, 
Jamia Hamdard, New Delhi-110062. 
 
Preparation of extracts 
The flower was dried at room tempera-
ture. After complete drying, it was pow-
dered and passed through a 60 mesh sieve 
and stored in air tight container. Dried 
powdered drug was used to prepare the ex-
tract. 150 g of the powdered flower was 
taken and extracted with water and metha-
nol in a soxhlet apparatus for 72 h. The ex-
tracts were evaporated to dryness in a rotary 
flash evaporator at a temperature not ex-
ceeding 60 °C. Preliminary phytochemical 
investigations of the extract which were 
conducted as per the procedures described 
by Kokate (1994) revealed the presence of 
flavonoids, saponins, carbohydrates, phe-
nolic compounds and alkaloids (Bhat et al., 
2012). The dried extracts (methanolic and 
aqueous) were preserved in desiccators un-
til further use. 
 
Animals 
Swiss albino mice of male sex (24-
34 g), supplied by the Central Animal 
House Facility of Jamia Hamdard, New 
Delhi (Registration no. 733/CPCSEA) were 
used. All animals were housed in cages in 
groups of 10, at 23-30 °C with a natural 
light-dark cycle. They had free access to 
standard pellet diet (Amrut Laboratory rat 
and mice feed, Navmaharashtra Chakanoil 
mills Ltd., Pune, India) and tap water. The 
study has been approved by the Ethics 
committee. Ethical norms were strictly fol-
lowed during all experimental procedures. 
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Assessment of anticonvulsant activity -  
Increasing Current Electroshock Seizures 
(ICES) 
The ICES as proposed by Kitano and 
Usui (1996), was used to evaluate the anti-
convulsant effect of the drugs. To start with 
a current of 2 mA electroshock to each 
mouse via ear electrodes as a single train of 
pulses (for 0.2 sec) was given with linearly 
increasing intensity of 2 mA/2 sec using an 
electroconvulsometer (INCO, Ambala, In-
dia). The current at which tonic Hind Limb 
Extension (THLE) occurred was recorded 
as the seizure threshold current (STC). 
When no tonic HLE was observed by a cur-
rent of 30 mA, electroshock was terminated 
(Kitano and Usui, 1996; Shahid and Pillai, 
2004). 
 
Experimental design 
The mice were divided into 6 groups 
(n=6) and treated with the respective test 
solutions as given below: 
Group I (Control): DW (10 ml/kg, b.w, p.o) 
Group II (Standard): Phenytoin (15 mg/kg, b.w, p.o) 
Group III (Test-I): NBAE (190 mg/kg b.w, p.o) 
Group IV (Test-II): NBAE (560 mg/kg b.w, p.o) 
Group V (Test-III): NBME (70 mg/kg b.w, p.o) 
Group VI (Test-IV): NBME (210 mg/kg b.w, p.o) 
 
PTZ-induced seizures 
PTZ at the dose of 60 mg/kg b.w. was 
injected i.p. to induce clonic tonic convul-
sions in mice. The test animals received 
methanolic and aqueous extracts orally and 
standard group received phenytoin 
(25 mg/kg b.w.) injected i.p. PTZ was in-
jected i.p. 60 min after the administration of 
drugs. Occurrence of hind limb tonic exten-
sion (THLE) and duration of seizures were 
noted. If no HLTE occurred during the time 
limit, the animals were considered protect-
ed (Vohora and Pal, 2000). 
 
Experimental design 
The mice were divided into 6 groups 
(n=6) and treated with the respective test 
solutions as given here: 
Group I (Control): DW (10 ml/kg b.w, p.o) 
Group II (Standard): Sodium valproate (300 mg/kg, 
b.w, p.o) 
Group III (Test-I): NBAE (190 mg/kg b.w, p.o) 
Group IV (Test-II): NBAE (560 mg/kg b.w, p.o) 
Group V (Test-III): NBME (70 mg/kg b.w, p.o) 
Group VI (Test-IV): NBME (210 mg/kg b.w, p.o) 
 
Statistical analysis 
The data were analysed using One-way 
analysis of variance (ANOVA) followed by 
Dunnett’s test. P values <0.05 were consid-
ered significant. 
 
RESULTS 
Effect of extracts on increasing current 
electroshock seizures (ICES) 
Phenytoin (15 mg/kg, p.o) showed 
66.7 % protection against ICES as evi-
denced by abolition of THLE. Methanolic 
extracts of Nepeta bractaeta at higher dose 
showed 33.3 % protection. Aqueous extract 
of Nepeta bractaeta at higher dose showed 
16.7 % protection respectively (Table 1). 
Nepeta bractaeta was not able to abol-
ish tonic hind limb extension at all the dos-
es used in this study but significantly re-
duced the duration of the tonic hind limb 
extension. Tonic hind limb extension is the 
universal feature of electroshock in mice, 
rats, rabbits, cats, monkeys and humans 
(Raza and Shaheen, 2001). Abolishing hind 
limb extension indicates the ability of test-
ing material to inhibit or prevent seizure 
discharge within brainstem seizure sub-
strate (Raza and Shaheen, 2001). All the 
currently available drugs that are clinically 
effective in the treatment of generalized 
tonic seizures (phenytoin, carbamazepine, 
phenobarbitone, valproate, lamotrigine, ox-
ycarbamazepine, etc.) are effective in elec-
troshock (McDonald and Althomsons, 
1998). 
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Table 1: Effects of extracts of Nepeta bractaeta in ICES induced convulsions  
S.NO. Group Dose (mg/kg, p.o) Seizure threshold 
current (mA) 
% protection 
from seizure 
1. Control 10 ml/kg DW 13.5±0.71 0 
2. PHT 15 30.5±1.23** 66.7 
3. NBAE 190 15.5±0.42 0 
4. NBAE 560 22.16±0.65* 16.7 
5. NBME 70 17.33±0.61 0 
6. NBME 210 25.16±0.47** 33.3 
Values are expressed as mean ± SE (n=6), *p<0.05, **p<0.01vs control 
 
 
Table 2: Effects of extracts of Nepeta bractaeta in PTZ induced convulsions  
S.NO. Group Dose 
(mg/kg, p.o.) 
Latency of myo-
clonic jerks (s) 
Latency of clonic 
generalized sei-
zures (s) 
% protec-
tion from 
seizure 
1. Control 10 ml/kg 65.5±3.72 228±1.08 0 
2. SVP 300 282.66±5.57** 1455.66±1.43** 50 
3. NBAE 190 70.83±6.55 247.3±18.14 0 
4. NBAE 560 83.16±3.65* 591.5±1.94* 0 
5. NBME 70 72.33±2.22 256.5±17.64 0 
6. NBME 210 186.66±6.05** 1035.5±1.47** 33.3 
Values are expressed as mean ± SE (n=6), *p<0.05, **p<0.01vs control 
 
 
Effect of extracts on pentylenetetrazole-
induced seizures (PTZ) 
The ability of an agent to prevent or de-
lay the onset of tonic and tonic-clonic con-
vulsion induced by PTZ in animals is an 
indication of anticonvulsant activity (Vel-
lucci and Webster, 1984; Amabeoku and 
Green, 2007), (Table 2). 
 
DISCUSSION 
Mental, neurological and behavioral 
disorders are common to all countries and 
cause immense suffering. People with these 
disorders are often subjected to social isola-
tion, poor quality of life, and increased 
mortality. These disorders are the cause of 
staggering economic and social costs. Ha-
bituation, dependence and the resulting po-
tential for addiction are the greater disad-
vantages of the modern synthetic psycho-
pharmacological agents. The abrupt discon-
tinuation of long-term therapy with these 
drugs leads to serious withdrawal symp-
toms. Therefore, modern society is now 
cautiously discovering traditional herbal 
medicines, particularly those which have 
been proved to be effective in controlled 
studies and which in some cases demon-
strated even better galenic properties than 
the conventional medicines. Unique oppor-
tunities for research exist in the field of 
CNS-active Indian medicinal plants (Weir, 
1965). 
Pharmacological evaluation of the anti-
convulsant properties of the aqueous and 
methanolic extracts of Nepeta bractaeta 
against PTZ induced seizure revealed that 
both the methanolic and aqueous extracts 
exhibited statistically significant and dose 
dependent delay in the onset of seizure; 
both extracts showed significant and dose 
dependent reduction in the duration of 
THLE. However, the methanolic extract 
was more active against PTZ induced con-
vulsion than the aqueous extract. On the 
other hand, both extracts showed significant 
and dose dependent reduction of the THLE 
induced by ICES. Tonic hind limb exten-
sion is the universal feature of electroshock 
in mice, rats, rabbits, cats, monkeys and 
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humans (Raza and Shaheen, 2001). Abol-
ishing hind limb extension indicates the 
ability of testing material to inhibit or pre-
vent seizure discharge within brainstem sei-
zure substrate (Raza and Shaheen, 2001). 
All the currently available drugs that are 
clinically effective in the treatment of gen-
eralized tonic seizures (phenytoin, carbam-
azepine, phenobarbitone, valproate, 
lamotrigine, oxycarbamazepine, etc.) are 
effective in electroshock (McDonald and 
Althomsons, 1998). And in the PTZ model 
both the methanolic and aqueous extracts 
exhibited statistically significant and dose 
dependent delay in the onset of seizure. The 
ability of an agent to prevent or delay the 
onset of tonic and tonic-clonic convulsion 
induced by PTZ in animals is an indication 
of anticonvulsant activity (Vellucci and 
Webster, 1984; Amabeoku and Green, 
2007). Anticonvulsant activity in PTZ-
induced seizures identifies compounds that 
can raise seizure threshold in brain (Raza 
and Shaheen., 2001). AEDs effective in the 
therapy of generalized seizures of petit mal 
type (absence of myoclonic) i.e. phenobar-
bitone, sodium valproate, ethosuximide and 
benzodiazepines suppress PTZ-induced sei-
zures in a dose-dependent manner (Loscher, 
2002). Sodium valproate which was used in 
this study as a reference anticonvulsant 
agent showed significant activity by delay-
ing the onset of myoclonic jerks and tonic 
convulsions and decreasing the frequency 
and duration of tonic convulsions.  
According to De Sarro and Ferreri 
(2003) PTZ may be exerting its convulsant 
effect by inhibiting the activity of GABA at 
GABAA receptors. GABA is the major in-
hibitory neurotransmitter which is implicat-
ed in epilepsy. The enhancement and inhi-
bition of the neurotransmission of GABA 
attenuates and enhances convulsion, respec-
tively (Meldrum, 1982). Anticonvulsant 
agents such as sodium valproate, diazepam 
and phenobarbitone inhibit PTZ-induced 
seizure by enhancing the action of GABAA-
receptors, thus facilitating the GABA-
mediated opening of chloride channels (Ol-
sen, 1981; Malizia and Nutt, 1995; Acharya 
et al., 2008). Postsynaptic GABAA-recep-
tors are multi-unit complexes with binding 
sites for the endogenous ligand GABA, 
benzodiazepines, barbiturates and other lig-
ands with a central chloride ion channel 
(Olsen and Leeb-Lundberg, 1981). Thus, 
the inhibition of PTZ-induced seizures by 
both the extracts in a dose dependent man-
ner suggests that they may produce this ef-
fect by enhancing GABAergic neurotrans-
mission although it is also possible that it 
could have done so by depressing gluta-
mate-mediated excitation. Phytochemical 
screening of the plant showed that the plant 
contains alkaloids, flavonoids, sterols, gly-
cosides and saponins, to which the anticon-
vulsant activity of the plant extracts may be 
attributed. 
 
CONCLUSION 
In conclusion, Nepeta bractaeta extracts 
may have potential anticonvulsant activity 
which may be due to the presence of certain 
active phytoconstituent. The anticonvulsant 
activity of Nepeta bractaeta may involve 
GABAergic transmission and glutaminergic 
transmission or sodium channel blockage. 
Further studies are, however, needed to iso-
late the active principle(s) of the plant and 
to enlighten the mechanism underlying its 
anticonvulsant effect. To this end we have 
to perform studies that will elucidate the 
exact mechanism of action of these active 
principle(s) before recommending these ex-
tracts for clinical application. 
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